2 ASX healthcare shares to buy today

CSL Limited (ASX:CSL) and this ASX healthcare shares could be the ones to buy right now. Here's what you need to know…

| More on:
Young doctor raising arms in air with hands in fists celebrating a new development

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One area of the share market that has been performing very positively over the last decade has been the healthcare sector.

Since this time in 2010, the S&P/ASX 200 Health Care index has generated a return of 432% for investors.

This has been driven by increased demand, better technologies and treatments, and ageing populations.

Given how these tailwinds are likely to remain for the long term, it isn't a surprise to see that healthcare shares are popular with ASX investors today.

But which healthcare shares should you buy? Here are two highly rated options:

Cochlear Limited (ASX: COH)

When it comes to shifting demographics, and particularly in respect to the growing number of over 65s, there are few companies that stand to benefit as much as Cochlear. It is the global developer, manufacturer, and distributor of cochlear implantable devices for the hearing impaired.

Late last month analysts at Macquarie put an outperform rating and $241.00 price target on Cochlear's shares. They have been pleased with both its market share gains and the positive opinion of its products by audiologists. This bodes well for its recovery from the pandemic and future growth.

CSL Limited (ASX: CSL)

CSL is one of the world's leading biotherapeutics companies. It has been a consistently strong performer over the last decade thanks to acquisitions, its research and development activities, growing plasma collection network, and its leading therapies. The latter includes therapies such as Privigen, Hizentra, Idelvion, and Afstyla.

One broker that is confident that this strong form can continue is UBS. Last week the investment bank retained its buy rating and $346.00 price target on the company's shares. While it notes that plasma collection conditions are tough in some markets because of COVID-19, it remains positive on its outlook. Especially given how it has a range of options to mitigate this headwind.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »